Kintara Therapeutics Inc: Tuhura's Lead Candidate, Ifx-2.0, Was Safe and Well Tolerated at Once Weekly Dosing for 3 Weeks
Tuhura的主要候選藥物Ifx-2.0連續3周每週一次劑量使用時安全且耐受良好。kintara therapeutics
Kintara Therapeutics Inc: Tuhura's Lead Candidate, Ifx-2.0, Was Safe and Well Tolerated at Once Weekly Dosing for 3 Weeks
Tuhura的主要候選藥物Ifx-2.0連續3周每週一次劑量使用時安全且耐受良好。kintara therapeutics
譯文內容由第三人軟體翻譯。